Publications: IBD (8)

Öhman L, Lasson A, Strömbeck A, Isaksson S, Hesselmar M, Simrén M, Strid H, Magnusson MK. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis - PubMed (nih.gov). Sci Rep. 2021 Apr 21;11(1):8641. doi: 10.1038/s41598-021-87973-7. PMID: 33883600; PMCID: PMC8060394.

Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C, Lindquist CM, Söderholm JD, Gomollón F, Kalla R, Satsangi J, Vatn MH, Jahnsen J, Halfvarson J, Ricanek P; Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character) - PubMed (nih.gov). Scand J Gastroenterol. 2020 Oct;55(10).

Strömbeck A, Lasson A, Strid H, et al. Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease - PubMed (nih.gov). BMC Gastroenterol. 2020;20(1):130. Published 2020 May 4.

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome - PubMed (nih.gov). Clin Exp Gastroenterol. 2019;12:37-49. Published 2019 Jan 31.

Magnusson MK, Strid H, Isaksson S, Simrén M, Öhman L. The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis - PubMed (nih.gov). Inflamm Bowel Dis. 2017;23(6):956-966.

Magnusson MK, Strid H, Sapnara M, et al. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition - PubMed (nih.gov). J Crohns Colitis. 2016;10(8):943-952.

Casén C, Vebø HC, Sekelja M, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD - PubMed (nih.gov). Aliment Pharmacol Ther. 2015;42(1):71-83.

Thorkildsen LT, Nwosu FC, Avershina E, et al. Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients - PubMed (nih.gov). Gastroenterol Res Pract. 2013;2013:636785.